Ivan Padilla-Diaz - Publications

Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 22, 2016

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041).

Journal: Investigational new drugs

Published: October 14, 2015

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia.

Journal: Gynecologic oncology

Published: December 30, 2014

Estimation of expectedness: predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer.

Journal: Cancer

Published: March 26, 2014

Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 12, 2014

Circulating and disseminated tumor cells in ovarian cancer: a systematic review.

Journal: Gynecologic oncology

Published: January 25, 2014

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment.

Journal: Ecancermedicalscience

Published: September 18, 2013

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors.

Journal: Investigational new drugs

Published: June 10, 2013

Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: September 06, 2012

Therapeutic management of epithelial ovarian cancer during pregnancy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 21, 2012

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours.

Journal: British journal of cancer

Published: July 19, 2012

Ovarian low-grade serous carcinoma: a comprehensive update.

Journal: Gynecologic oncology

Published: April 17, 2012